The adeno-associated virus vector for orthopaedic gene therapy

Clinical Orthopaedics and Related Research

Volumn 379, Issue SUPPL., 2000, Pages

  Schwarz, E M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; GENE PRODUCT; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; CONFERENCE PAPER; CYTOTOXICITY; DOG; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMOPHILIA B; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MUSCULOSKELETAL DISEASE; NONHUMAN; ORTHOPEDICS; PRIORITY JOURNAL; TRANSGENE; VIRUS RECOMBINANT; VIRUS TITRATION;

EID: 0033778630     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200010001-00005     Document Type: Conference Paper

References (55)

1. In vivo model of adeno-associated virus vector persistence and rescue
2. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors
3. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors
4. Dissociation of carcinogen-induced SV40 DNA-amplification and amplification of AAV DNA in a Chinese hamster cell line
5. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma) 2 antibody
6. Herpesviruses provide helper functions for avian adeno-associated parvovirus
7. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction
8. Parvovirus replication
9. Biology of adeno-associated virus
10. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication
11. Immune responses to adenovirus and adeno-associated virus in humans
12. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
13. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors
14. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue
15. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)
16. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
17. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
18. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
19. Empirical advantages of adeno-associated viral vectors for in vivo gene therapy for arthritis
20. Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV- 2
21. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system
22. Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells
23. The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors
24. Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model
25. Studies of small DNA viruses found in various adenovirus preparations: Physical, biological, and immunological characteristics
26. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line
27. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors
28. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter
29. A pilot study of the effect of oral 8-methoxypsoralen and intraarticular ultraviolet light on rheumatoid synovitis
30. The genetics of adeno-associated virus
31. Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model
32. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells
33. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
34. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors
35. Adeno-associated virus vectors preferentially transduce cells in S phase
36. Cloning of adeno-associated virus into pBR322: Rescue of intact virus from the recombinant plasmid in human cells
37. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
38. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
39. Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV
40. Targeted integration of adeno-associated virus (AAV) into human chromosome 19
41. Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation, of transduction
42. Characteristics and taxonomy of Parvoviridae
43. Nucleotide sequence and organization of the adeno-associated virus 2 genome
44. Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis
45. Alpha V-beta5 integrin: A co-receptor for adeno-associated virus type 2 infection
46. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
47. Rolling hairpin model for replication of parvovirus and linear chromosomal DNA
48. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein
49. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA
50. Adeno-viral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws
51. Gene therapy vectors based on adeno-associated virus type 1
52. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
53. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress
54. Replication of adeno-associated virus is synchronized cells without the addition of a helper virus
55. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield